Clinical Trial Update: FluMist in Egg Allergic Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on FluMist in egg-allergic individuals, covering Phase 1 and Phase 2 completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Egg Allergy
• Influenza Vaccination

Drugs mentioned

• FluMist (live attenuated influenza vaccine)

Snippet

Sponsor: Walter Reed Army Medical Center | Conditions: Egg Allergy, Eligible for Vaccination Against Influenza | Phase 1, Phase 2 | Status: COMPLETED